A Translational Neuroscience & Computational Evaluation of a D1R Partial Agonist for Schizophrenia (TRANSCENDS): Rationale and Study Design of a Brain-Based Clinical Trial

Fonteneau C, Tamayo Z, Price A, Pan L, Afriyie-Agyemang Y, Agrawal S, Butler A, Cail C, Calkins M, Chakilam S, Forselius-Bielen K, Fram G, Frazier A, Gil R, Govil P, Gray DL, Grinband J, Gur RC, Haubold NK, Heffernan Z, Kegeles L, Kohler C, Lin C, Lu J, Mayer M, Pham P, Perlman G, Rahmati M, Ranganathan M, Santamauro NP, Schutte CT, Selloni A, Van Snellenberg J, Surti T, Wolf DH, Zharyy C, TRANSCENDS Group, Abi-Dargham A, Gur RE, Lieberman JA, Kantrowitz JT, Anticevic A, Cho YT, Krystal JH.

Open source

DOI
10.1101/2025.04.18.25326082
Published
2025-04-20
Container
Not recorded
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 39/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1101/2025.04.18.25326082,
  title = {A Translational Neuroscience \& Computational Evaluation of a D1R Partial Agonist for Schizophrenia (TRANSCENDS): Rationale and Study Design of a Brain-Based Clinical Trial},
  author = {Fonteneau C and  Tamayo Z and  Price A and  Pan L and  Afriyie-Agyemang Y and  Agrawal S and  Butler A and  Cail C and  Calkins M and  Chakilam S and  Forselius-Bielen K and  Fram G and  Frazier A and  Gil R and  Govil P and  Gray DL and  Grinband J and  Gur RC and  Haubold NK and  Heffernan Z and  Kegeles L and  Kohler C and  Lin C and  Lu J and  Mayer M and  Pham P and  Perlman G and  Rahmati M and  Ranganathan M and  Santamauro NP and  Schutte CT and  Selloni A and  Van Snellenberg J and  Surti T and  Wolf DH and  Zharyy C and  TRANSCENDS Group and  Abi-Dargham A and  Gur RE and  Lieberman JA and  Kantrowitz JT and  Anticevic A and  Cho YT and  Krystal JH.},
  year = {2025},
  doi = {10.1101/2025.04.18.25326082},
  url = {https://doi.org/10.1101/2025.04.18.25326082}
}

RIS

TY  - JOUR
TI  - A Translational Neuroscience & Computational Evaluation of a D1R Partial Agonist for Schizophrenia (TRANSCENDS): Rationale and Study Design of a Brain-Based Clinical Trial
AU  - Fonteneau C
AU  -  Tamayo Z
AU  -  Price A
AU  -  Pan L
AU  -  Afriyie-Agyemang Y
AU  -  Agrawal S
AU  -  Butler A
AU  -  Cail C
AU  -  Calkins M
AU  -  Chakilam S
AU  -  Forselius-Bielen K
AU  -  Fram G
AU  -  Frazier A
AU  -  Gil R
AU  -  Govil P
AU  -  Gray DL
AU  -  Grinband J
AU  -  Gur RC
AU  -  Haubold NK
AU  -  Heffernan Z
AU  -  Kegeles L
AU  -  Kohler C
AU  -  Lin C
AU  -  Lu J
AU  -  Mayer M
AU  -  Pham P
AU  -  Perlman G
AU  -  Rahmati M
AU  -  Ranganathan M
AU  -  Santamauro NP
AU  -  Schutte CT
AU  -  Selloni A
AU  -  Van Snellenberg J
AU  -  Surti T
AU  -  Wolf DH
AU  -  Zharyy C
AU  -  TRANSCENDS Group
AU  -  Abi-Dargham A
AU  -  Gur RE
AU  -  Lieberman JA
AU  -  Kantrowitz JT
AU  -  Anticevic A
AU  -  Cho YT
AU  -  Krystal JH.
PY  - 2025
DO  - 10.1101/2025.04.18.25326082
UR  - https://doi.org/10.1101/2025.04.18.25326082
ER  -

APA

C, F., Z, T., A, P., L, P., Y, A., S, A., A, B., C, C., M, C., S, C., K, F., G, F., A, F., R, G., P, G., DL, G., J, G., RC, G., NK, H., Z, H., L, K., C, K., C, L., J, L., M, M., P, P., G, P., M, R., M, R., NP, S., CT, S., A, S., J, V. S., T, S., DH, W., C, Z., Group, T., A, A., RE, G., JA, L., JT, K., A, A., YT, C., & JH., K. (2025). A Translational Neuroscience & Computational Evaluation of a D1R Partial Agonist for Schizophrenia (TRANSCENDS): Rationale and Study Design of a Brain-Based Clinical Trial. https://doi.org/10.1101/2025.04.18.25326082

Source records